[HTML][HTML] Potential of biosimilars to increase access to biologics: considerations for advanced practice providers in oncology
SM Tinsley, C Grande, K Olson, L Plato… - Journal of the …, 2018 - ncbi.nlm.nih.gov
Biosimilars are biologic products that are highly similar, but not identical, to a licensed
reference (or" originator") biologic product. These agents have the potential to provide …
reference (or" originator") biologic product. These agents have the potential to provide …
The language of biosimilars: clarification, definitions, and regulatory aspects
P Declerck, R Danesi, D Petersel, I Jacobs - Drugs, 2017 - Springer
Biologic therapies have revolutionized treatment of a number of diseases. Patents and
exclusivity for a number of biologics are expiring. This has created the opportunity for the …
exclusivity for a number of biologics are expiring. This has created the opportunity for the …
Biosimilars: hope and concern
CE Emmanouilides, MI Karampola… - Journal of Oncology …, 2016 - journals.sagepub.com
As patents of the first introduced biologic therapeutics in oncology have begun to expire,
competing pharmaceutical companies are allowed to produce and market the same protein …
competing pharmaceutical companies are allowed to produce and market the same protein …
[PDF][PDF] The future of biological therapy: a pathway forward for biosimilars
RO Dolinar, MS Reilly - GaBI J, 2013 - gabi-journal.net
Biologicals are large, complex molecule drugs that treat serious illnesses. They are created
using proprietary and unique processes involving living cells, and range from sugars and …
using proprietary and unique processes involving living cells, and range from sugars and …
[HTML][HTML] The regulatory landscape of biosimilars: WHO efforts and progress made from 2009 to 2019
HN Kang, R Thorpe, I Knezevic, CDRZ Blades… - Biologicals, 2020 - Elsevier
Abstract The World Health Assembly in 2014 adopted a resolution that mandates both
Member States and the WHO Secretariat to facilitate access to biotherapeutic products in a …
Member States and the WHO Secretariat to facilitate access to biotherapeutic products in a …
Biosimilars in an era of rising oncology treatment options
M Peeters, D Planchard, M Pegram, J Gonçalves… - Future …, 2021 - Taylor & Francis
New diagnostic technologies, including molecular profiling, have enabled advances in
treatments of various cancers; this has significantly improved clinical outcomes, including …
treatments of various cancers; this has significantly improved clinical outcomes, including …
Biosimilars: science, implications, and potential outlooks in the Middle East and Africa
RA Batran, M Elmoshneb, AS Hussein… - … : Targets and Therapy, 2022 - Taylor & Francis
Biosimilars are biological products that efficiently replicate the function of the originator
products. They have changed the prognosis of millions of patients with many serious …
products. They have changed the prognosis of millions of patients with many serious …
Are biosimilars really generics?
A Misra - Expert opinion on biological therapy, 2010 - Taylor & Francis
Importance of the field: Ever since the formation of the first biotechnology company almost
three decades ago, more than 150 biopharmaceutical products have been marketed across …
three decades ago, more than 150 biopharmaceutical products have been marketed across …
Biosimilars–science, status, and strategic perspective
GB Kresse - European Journal of Pharmaceutics and …, 2009 - Elsevier
Biopharmaceuticals based on recombinant proteins have started to go off-patent, opening
the way for other manufacturers to place follow-on products to the market. Meanwhile it has …
the way for other manufacturers to place follow-on products to the market. Meanwhile it has …
Biosimilars and the European experience: implications for the United States
Biologics are medicines derived from a biological source. Their high prices and rapid uptake
have raised hopes that with the gradual expiration of patents on the first generations of …
have raised hopes that with the gradual expiration of patents on the first generations of …